The California Institute for Regenerative Medicine expects to be taking part in 10 early-stage clinical trials this year, an achievement that it points to with pride; however, no California-financed cures or therapies have reached the clinic and none are likely to do so for years.
The California Institute for Regenerative Medicine expects to be taking part in 10 early-stage clinical trials this year, an achievement that it points to with pride; however, no California-financed cures or therapies have reached the clinic and none are likely to do so for years. Autumn Payne Sacramento Bee file
The California Institute for Regenerative Medicine expects to be taking part in 10 early-stage clinical trials this year, an achievement that it points to with pride; however, no California-financed cures or therapies have reached the clinic and none are likely to do so for years. Autumn Payne Sacramento Bee file